- Home
- FLYW vs ABSI Comparison
FLYW vs ABSI Comparison
Compare FLYW & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLYW | ABSI |
|---|---|---|
| Founded | 2009 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.9B |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FLYW | ABSI |
|---|---|---|
| Price | $18.69 | $10.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 11 |
| Target Price | ★ $21.15 | $14.40 |
| AVG Volume (30 Days) | 1.3M | ★ 4.0M |
| Earning Date | 11-03-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 450.00 | 10.64 |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $623,025,000.00 | $4,534,000.00 |
| Revenue This Year | $22.17 | $39.03 |
| Revenue Next Year | $15.45 | $310.91 |
| P/E Ratio | $614.33 | ★ N/A |
| Revenue Growth | ★ 26.59 | N/A |
| 52 Week Low | $10.55 | $2.24 |
| 52 Week High | $19.73 | $12.06 |
Technical Indicators
Market Signals| Indicator | FLYW | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 63.59 | 53.35 |
| Support Level | $16.95 | $9.25 |
| Resistance Level | $19.02 | $11.66 |
| Average True Range (ATR) | 0.50 | 0.90 |
| MACD | 0.16 | -0.08 |
| Stochastic Oscillator | 99.00 | 44.64 |
Price Performance
Historical ComparisonAbout FLYW Flywire Corporation Voting
Flywire Corp provides a secure payment platform, offering its clients a streamlined process to receive reconciled domestic and international payments more cost-effectively and efficiently. The company's solutions are built on three core elements, namely a payments platform, a proprietary payment network, and vertical-specific software backed by its deep industry expertise. Geographically, the majority of revenue is from the Americas.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.